| Ms Corinne L Puzio, MD | |
|
31 Village Sq, Chelmsford, MA 01824-2712 | |
| (978) 256-9507 | |
| Not Available |
| Full Name | Ms Corinne L Puzio |
|---|---|
| Gender | Female |
| Speciality | Urology |
| Experience | 15 Years |
| Location | 31 Village Sq, Chelmsford, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558597906 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 278196 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lowell General Hospital | Lowell, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lgh Medical Group, Inc. | 3173626751 | 101 |
News Archive
Clinical studies of a generic drug called salsalate, widely prescribed for arthritis, now provide early promising results that it may be useful for the treatment of patients with type 2 diabetes as well.
Medical professionals, business and government officials from around the world joined in Amsterdam on the sidelines of the ECCMID 2016 Conference, hosted by the European Society of Clinical Microbiology and Infectious Diseases to declare their commitment to fight antimicrobial resistance (AMR) in a concerted effort.
As part of a German-French research project, a team led by Dr. Christa E. Müller from the University of Bonn and Dr. David Blum from the University of Lille was able to demonstrate for the first time that caffeine has a positive effect on tau deposits in Alzheimer's disease.
Reverse Medical Corporation today announced FDA clearance for US commercialization of their MVP-5 Micro Vascular Plug system for peripheral vessel embolization, and the first US clinical case. The MVP-5 system is indicated for use to obstruct or reduce the rate of blood flow in the peripheral vasculature, in vessels measuring between 3.0 and 5.0 mm.
Alnylam Pharmaceuticals, Inc. has announced new results from its ongoing Phase 2 open-label extension (OLE) studies with patisiran and revusiran, investigational RNAi therapeutics targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis (ATTR amyloidosis).
› Verified 3 days ago
| Entity Name | Merrimack Urology Assoc, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316976269 PECOS PAC ID: 4284532102 Enrollment ID: O20031230000066 |
News Archive
Clinical studies of a generic drug called salsalate, widely prescribed for arthritis, now provide early promising results that it may be useful for the treatment of patients with type 2 diabetes as well.
Medical professionals, business and government officials from around the world joined in Amsterdam on the sidelines of the ECCMID 2016 Conference, hosted by the European Society of Clinical Microbiology and Infectious Diseases to declare their commitment to fight antimicrobial resistance (AMR) in a concerted effort.
As part of a German-French research project, a team led by Dr. Christa E. Müller from the University of Bonn and Dr. David Blum from the University of Lille was able to demonstrate for the first time that caffeine has a positive effect on tau deposits in Alzheimer's disease.
Reverse Medical Corporation today announced FDA clearance for US commercialization of their MVP-5 Micro Vascular Plug system for peripheral vessel embolization, and the first US clinical case. The MVP-5 system is indicated for use to obstruct or reduce the rate of blood flow in the peripheral vasculature, in vessels measuring between 3.0 and 5.0 mm.
Alnylam Pharmaceuticals, Inc. has announced new results from its ongoing Phase 2 open-label extension (OLE) studies with patisiran and revusiran, investigational RNAi therapeutics targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis (ATTR amyloidosis).
› Verified 3 days ago
| Entity Name | Lgh Medical Group, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174698385 PECOS PAC ID: 3173626751 Enrollment ID: O20070320000453 |
News Archive
Clinical studies of a generic drug called salsalate, widely prescribed for arthritis, now provide early promising results that it may be useful for the treatment of patients with type 2 diabetes as well.
Medical professionals, business and government officials from around the world joined in Amsterdam on the sidelines of the ECCMID 2016 Conference, hosted by the European Society of Clinical Microbiology and Infectious Diseases to declare their commitment to fight antimicrobial resistance (AMR) in a concerted effort.
As part of a German-French research project, a team led by Dr. Christa E. Müller from the University of Bonn and Dr. David Blum from the University of Lille was able to demonstrate for the first time that caffeine has a positive effect on tau deposits in Alzheimer's disease.
Reverse Medical Corporation today announced FDA clearance for US commercialization of their MVP-5 Micro Vascular Plug system for peripheral vessel embolization, and the first US clinical case. The MVP-5 system is indicated for use to obstruct or reduce the rate of blood flow in the peripheral vasculature, in vessels measuring between 3.0 and 5.0 mm.
Alnylam Pharmaceuticals, Inc. has announced new results from its ongoing Phase 2 open-label extension (OLE) studies with patisiran and revusiran, investigational RNAi therapeutics targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis (ATTR amyloidosis).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Corinne L Puzio, MD 31 Village Sq, Chelmsford, MA 01824-2712 Ph: (978) 256-9507 | Ms Corinne L Puzio, MD 31 Village Sq, Chelmsford, MA 01824-2712 Ph: (978) 256-9507 |
News Archive
Clinical studies of a generic drug called salsalate, widely prescribed for arthritis, now provide early promising results that it may be useful for the treatment of patients with type 2 diabetes as well.
Medical professionals, business and government officials from around the world joined in Amsterdam on the sidelines of the ECCMID 2016 Conference, hosted by the European Society of Clinical Microbiology and Infectious Diseases to declare their commitment to fight antimicrobial resistance (AMR) in a concerted effort.
As part of a German-French research project, a team led by Dr. Christa E. Müller from the University of Bonn and Dr. David Blum from the University of Lille was able to demonstrate for the first time that caffeine has a positive effect on tau deposits in Alzheimer's disease.
Reverse Medical Corporation today announced FDA clearance for US commercialization of their MVP-5 Micro Vascular Plug system for peripheral vessel embolization, and the first US clinical case. The MVP-5 system is indicated for use to obstruct or reduce the rate of blood flow in the peripheral vasculature, in vessels measuring between 3.0 and 5.0 mm.
Alnylam Pharmaceuticals, Inc. has announced new results from its ongoing Phase 2 open-label extension (OLE) studies with patisiran and revusiran, investigational RNAi therapeutics targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis (ATTR amyloidosis).
› Verified 3 days ago
Dr. Matthew A Cohen, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 31 Village Sq, Chelmsford, MA 01824 Phone: 978-256-9507 | |
Mr. Mark Henry, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 31 Village Sq, Chelmsford, MA 01824 Phone: 978-256-9507 Fax: 978-256-6955 | |
Richard Eliot Altman, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 31 Village Sq, Chelmsford, MA 01824 Phone: 978-256-9507 | |
J Mathieu Massicotte, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 31 Village Sq, Chelmsford, MA 01824 Phone: 978-256-9507 | |
Dr. David Wu Shi, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 31 Village Sq, Chelmsford, MA 01824 Phone: 978-256-9506 | |
David Berman, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 31 Village Sq, Chelmsford, MA 01824 Phone: 978-256-9507 |